Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
Michael Shapiro, President of American Society for Preventive Cardiology (ASPC), shared Carlos Andrés Vergara Sánchez‘s post on LinkedIn, adding:
“Grateful to Carlos Andrés Vergara Sánchez for the generous words. Seeing fellows and early-career colleagues engage deeply in preventive cardiology is exactly why we launched these efforts.
At the American Society for Preventive Cardiology (ASPC), we are committed to creating real pathways for trainees who want to build careers in prevention.
The ASPC Training Academy and the AJPC Academy are two examples of how we are investing in mentorship, scholarship, and leadership development.
If you are interested in preventive cardiology, I encourage you to get involved. The future of the field depends on you.
Khurram Nasir and Carlos Andrés Vergara Sánchez, thank you for your leadership and partnership.”
Carlos Andrés Vergara Sánchez, Chief Cardiovascular Disease Fellow at Mayo Clinic College of Medicine and Science, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“The American Journal of Preventive Cardiology and American Society for Preventive Cardiology are investing in the future of academic preventive cardiology.
Under the leadership of Dr Michael Shapiro and Dr Khurram Nasir, their commitment to supporting trainees and early-career physicians has never been more tangible — all in service of better science and better patient care.
I’ve had the privilege of witnessing firsthand the energy and intention behind this effort.
The AJPC Academy is turning vision into opportunity for colleagues across the country.
Honored to be part of this incredible initiative.
Read more in the new publication”
Tilte: AJPC academy: A four-pillar model for cultivating the next generation of academic leaders in cardiovascular prevention
Authors: Carlos Vergara Sanchez, Ramzi Dudum, Michael D. Shapiro, Khurram Nasir
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies